Literature DB >> 11568300

Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease.

D Shingadia1, M O'Gorman, A H Rowley, S T Shulman.   

Abstract

Kawasaki disease (KD) is an acute vasculitis of young childhood predominantly affecting the coronary arteries. IgA plasma cells have been found to infiltrate vascular and nonvascular tissues in fatal acute KD. To determine whether IgA B-lymphocytes were increased in the peripheral blood of patients with KD, we performed three-color flow cytometry to detect surface and cytoplasmic immunoglobulin expression (IgA, IgM, IgD, and IgG) of peripheral B-lymphocytes in KD patients during the acute, subacute, and convalescent stages of illness and in age-matched febrile and afebrile pediatric controls. Surprisingly, absolute numbers of B-lymphocytes expressing IgA were found to be significantly lower in peripheral blood of acute KD patients compared with febrile and afebrile pediatric controls. These findings indicate that IgA plasma cells are not present in KD tissue as a result of excess numbers of these IgA B-lymphocytes in peripheral blood. We speculate that IgA B-lymphocytes are selectively withdrawn from the peripheral circulation into KD target tissues as part of a specific IgA immune response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568300     DOI: 10.1203/00006450-200110000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Authors:  L Giordani; M G Quaranta; A Marchesi; E Straface; D Pietraforte; A Villani; W Malorni; D Del Principe; M Viora
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

3.  Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Authors:  Arthur J Chang; Sarah Baron; Jonathon Hoffman; Mark D Hicar
Journal:  Mol Immunol       Date:  2022-03-15       Impact factor: 4.174

4.  Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.

Authors:  Meghan Martin; Brian H Wrotniak; Mark Hicar
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

5.  Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children.

Authors:  Rachel Engelberg; Meghan Martin; Brian H Wrotniak; Mark Daniel Hicar
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-20       Impact factor: 3.054

6.  Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.

Authors:  Meng Xu; Yanfang Jiang; Jinghua Wang; Jinxiang Liu; Congcong Liu; Deying Liu; Sirui Yang
Journal:  BMC Immunol       Date:  2019-06-03       Impact factor: 3.615

7.  Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease.

Authors:  Meng Xu; Yanfang Jiang; Jian Zhang; Yan Zheng; Deying Liu; Lishuang Guo; Sirui Yang
Journal:  BMC Immunol       Date:  2018-12-27       Impact factor: 3.615

8.  Important role of CCR2 in a murine model of coronary vasculitis.

Authors:  Hernan G Martinez; Marlon P Quinones; Fabio Jimenez; Carlos Estrada; Kassandra M Clark; Kazuo Suzuki; Noriko Miura; Naohito Ohno; Sunil K Ahuja; Seema S Ahuja
Journal:  BMC Immunol       Date:  2012-10-17       Impact factor: 3.615

9.  Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented diet.

Authors:  Padmaja Shastri; Justin McCarville; Martin Kalmokoff; Stephen P J Brooks; Julia M Green-Johnson
Journal:  Biol Sex Differ       Date:  2015-08-06       Impact factor: 5.027

Review 10.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.